The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bunge Ltd

NYSE: BG
Last

(U.S.) $51.46

Today's change+4.05 +8.54%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.
 

Bunge Ltd

NYSE: BG
Last

(U.S.) $51.46

Today's change+4.05 +8.54%
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Bunge Ltd up sharply

Bunge Ltd closed up sharply Friday, rallying (U.S.)$4.05 or 8.54% to (U.S.)$51.46. Over the last five days, shares have lost 13.41% and are down 24.63% for the last year to date. This security has underperformed the S&P 500 by 25.32% during the last year.

Key company metrics

  • Open(U.S.) $48.43
  • Previous close(U.S.) $47.41
  • High(U.S.) $51.99
  • Low(U.S.) $48.36
  • Bid / Ask-- / --
  • YTD % change-24.63%
  • Volume3,751,953
  • Average volume (10-day)2,035,136
  • Average volume (1-month)1,573,040
  • Average volume (3-month)1,282,256
  • 52-week range(U.S.) $46.08 to (U.S.) $93.04
  • Beta0.98
  • Trailing P/E17.17×
  • P/E 1 year forward7.54×
  • Forward PEG0.45×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.95%
  • Trailing EPS(U.S.) $3.00
Updated February 12 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.12%

Based on its net profit margin of 1.12%, Bunge Ltd is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue10,76210,78210,80613,231
Total other revenue--------
Total revenue10,76210,78210,80613,231
Gross profit745535710695
Total cost of revenue10,01710,24710,09612,536
Total operating expense10,37510,60810,42713,066
Selling / general / administrative358361331530
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income387174379165
Interest income (expense), net non-operating-77-57-53-122
Gain (loss) on sale of assets--------
Other--------
Income before tax35313733159
Income after tax21392246-40
Income tax, total140458599
Net income23986263-54
Total adjustments to net income-10-14-14-8
Net income before extra. items21885249-49
Minority interest5-73-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items20871235-57
Inc. avail. to common incl. extra. items22972249-62
Diluted net income22972249-62
Dilution adjustment----00
Diluted weighted average shares152145154145
Diluted EPS excluding extraordinary itemsvalue per share1.370.491.53-0.39
Dividends per sharevalue per share0.380.380.340.34
Diluted normalized EPSvalue per share1.370.491.53-0.39